Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: A multicenter study of 132 patients-Reference-Cited by-同舟云学术

Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: A multicenter study of 132 patients

Published:2017-10 Issue:2 Volume:47 Page:288-294
ISSN:0049-0172
Container-title:Seminars in Arthritis and Rheumatism
language:en
Short-container-title:Seminars in Arthritis and Rheumatism

Author:

Jamilloux Yvan,Cohen-Aubart Fleur,Chapelon-Abric Catherine,Maucort-Boulch Delphine,Marquet Alicia,Pérard Laurent,Bouillet Laurence,Deroux Alban,Abad Sébastien,Bielefeld Philip,Bouvry Diane,André Marc,Noel Nicolas,Bienvenu Boris,Proux Alice,Vukusic Sandra,Bodaghi Bahram,Sarrot-Reynauld Françoise,Iwaz Jean,Amoura Zahir,Broussolle Christiane,Cacoub Patrice,Saadoun David,Valeyre Dominique,Sève Pascal

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Rheumatology

Reference31 articles.

1. Sarcoidosis;Valeyre;Lancet,2014

2. Established and experimental medical therapy of pulmonary sarcoidosis;Baughman;Eur Respir J,2013

3. Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis;Vorselaars;Eur Respir J,2014

4. Etanercept for refractory ocular sarcoidosis: results of a double-blind randomized trial;Baughman;Chest,2005

5. Inhibitors of tumor necrosis factor (TNF) in sarcoidosis: who, what, and how to use them;Baughman,2008

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting cytokine networks in neuroinflammatory diseases;Nature Reviews Drug Discovery;2024-09-11

2. Granulomatous myositis: characteristics and outcome from a monocentric retrospective cohort study;Neuromuscular Disorders;2024-09

3. Efficacy and safety of Infliximab in systemic sarcoidosis according to GenPhenReSa organ-involvement phenotype: a retrospective study of 55 patients;Respiratory Research;2024-03-14

4. Anti-inflammatory Therapy for Sarcoidosis;Clinics in Chest Medicine;2024-03

5. Developmental drugs for sarcoidosis;Journal of Autoimmunity;2024-03